A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid ursodeoxycholic manufactured by the university hospital for the treatment of primary biliary cholangitis

BACKGROUND: Health care costs are growing faster than the rest of the global economy, according to the World Health Organization (WHO). Countries’ health expenditures include paying for general medicine, diagnostic procedures, hospitalizations and surgeries, as well as medications and prescribed tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakano, Larissa Akeme, Cançado, Eduardo Luiz Rachid, Chaves, Cleuber Esteves, Madeira, Maria Cristina Vaz, Katayose, Jéssica Toshie, Nabeshima, Mariana Akemi, Fossaluza, Victor, Uhrigshardt, Gabriela Guimarães, Liting, Zheng, Pinto, Vanusa Barbosa, Carrilho, Flair José, Ono, Suzane Kioko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406387/
https://www.ncbi.nlm.nih.gov/pubmed/32758152
http://dx.doi.org/10.1186/s12876-020-01399-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406387/
https://www.ncbi.nlm.nih.gov/pubmed/32758152
http://dx.doi.org/10.1186/s12876-020-01399-5

Ejemplares similares